{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:48:53Z","timestamp":1783050533425,"version":"3.54.6"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["#2016M3A9B6026771"],"award-info":[{"award-number":["#2016M3A9B6026771"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019R1I1A1A01060265"],"award-info":[{"award-number":["NRF-2019R1I1A1A01060265"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Massive death of cardiomyocytes is a major feature of cardiovascular diseases. Since the regenerative capacity of cardiomyocytes is limited, the regulation of their death has been receiving great attention. The cell death of cardiomyocytes is a complex mechanism that has not yet been clarified, and it is known to appear in various forms such as apoptosis, necrosis, etc. In ischemic heart disease, the apoptosis and necrosis of cardiomyocytes appear in two types of programmed forms (intrinsic and extrinsic pathways) and they account for a large portion of cell death. To repair damaged cardiomyocytes, diverse stem cell therapies have been attempted. However, despite the many positive effects, the low engraftment and survival rates have clearly limited the application of stem cells in clinical therapy. To solve these challenges, the introduction of the desired genes in stem cells can be used to enhance their capacity and improve their therapeutic efficiency. Moreover, as genome engineering technologies have advanced significantly, safer and more stable delivery of target genes and more accurate deletion of genes have become possible, which facilitates the genetic modification of stem cells. Accordingly, stem cell therapy for damaged cardiac tissue is expected to further improve. This review describes myocardial cell death, stem cell therapy for cardiac repair, and genome-editing technologies. In addition, we introduce recent stem cell therapies that incorporate genome-editing technologies in the myocardial infarction model.<\/jats:p>","DOI":"10.1007\/s12015-020-10096-5","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T16:07:04Z","timestamp":1611590824000},"page":"1264-1279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cardiomyocyte Death and Genome-Edited Stem Cell Therapy for Ischemic Heart Disease"],"prefix":"10.1007","volume":"17","author":[{"given":"Hyun-Min","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1030-3577","authenticated-orcid":false,"given":"Je-Yoel","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"10096_CR1","unstructured":"Xu, J., et al. Mortality in the United States, 2018. NCHS Data in Brief, 2020(355), 1\u20138."},{"key":"10096_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/B978-0-12-394309-5.00006-7","volume":"298","author":"T Kalogeris","year":"2012","unstructured":"Kalogeris, T., et al. (2012). Cell biology of ischemia\/reperfusion injury. International Review of Cell and Molecular Biology, 298, 229\u2013317.","journal-title":"International Review of Cell and Molecular Biology"},{"issue":"11","key":"10096_CR3","first-page":"774","volume":"38","author":"G Heusch","year":"2017","unstructured":"Heusch, G., & Gersh, B. J. (2017). The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: A continual challenge. European Heart Journal, 38(11), 774\u2013784.","journal-title":"European Heart Journal"},{"key":"10096_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.130","volume":"2","author":"M Chiong","year":"2011","unstructured":"Chiong, M., Wang, Z. V., Pedrozo, Z., Cao, D. J., Troncoso, R., Ibacache, M., Criollo, A., Nemchenko, A., Hill, J. A., & Lavandero, S. (2011). Cardiomyocyte death: Mechanisms and translational implications. Cell Death & Disease, 2, e244.","journal-title":"Cell Death & Disease"},{"key":"10096_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0022-1910(65)90099-5","volume":"11","author":"RA Lockshin","year":"1965","unstructured":"Lockshin, R. A., & Williams, C. M. (1965). Programmed cell death \u2013 I. Cytology of degeneration in the intersegmental muscles of the Pernyi Silkmoth. Journal of Insect Physiology, 11, 123\u2013133.","journal-title":"Journal of Insect Physiology"},{"issue":"5","key":"10096_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.18632\/aging.100459","volume":"4","author":"B Favaloro","year":"2012","unstructured":"Favaloro, B., Allocati, N., Graziano, V., di Ilio, C., & de Laurenzi, V. (2012). Role of apoptosis in disease. Aging (Albany NY), 4(5), 330\u2013349.","journal-title":"Aging (Albany NY)"},{"issue":"15","key":"10096_CR7","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1101\/gad.13.15.1899","volume":"13","author":"A Gross","year":"1999","unstructured":"Gross, A., McDonnell, J. M., & Korsmeyer, S. J. (1999). BCL-2 family members and the mitochondria in apoptosis. Genes & Development, 13(15), 1899\u20131911.","journal-title":"Genes & Development"},{"key":"10096_CR8","doi-asserted-by":"crossref","unstructured":"McIlwain, D. R., Berger, T., & Mak, T. W. (2015). Caspase functions in cell death and disease. Cold Spring Harbor Perspectives in Biology, 7(4).","DOI":"10.1101\/cshperspect.a026716"},{"issue":"8","key":"10096_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/sj.cdd.4400883","volume":"8","author":"G Denecker","year":"2001","unstructured":"Denecker, G., Vercammen, D., Steemans, M., vanden Berghe, T., Brouckaert, G., van Loo, G., Zhivotovsky, B., Fiers, W., Grooten, J., Declercq, W., & Vandenabeele, P. (2001). Death receptor-induced apoptotic and necrotic cell death: Differential role of caspases and mitochondria. Cell Death and Differentiation, 8(8), 829\u2013840.","journal-title":"Cell Death and Differentiation"},{"issue":"3","key":"10096_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.chom.2012.01.016","volume":"11","author":"JW Upton","year":"2012","unstructured":"Upton, J. W., Kaiser, W. J., & Mocarski, E. S. (2012). DAI\/ZBP1\/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host & Microbe, 11(3), 290\u2013297.","journal-title":"Cell Host & Microbe"},{"issue":"43","key":"10096_CR11","doi-asserted-by":"publisher","first-page":"31268","DOI":"10.1074\/jbc.M113.462341","volume":"288","author":"WJ Kaiser","year":"2013","unstructured":"Kaiser, W. J., Sridharan, H., Huang, C., Mandal, P., Upton, J. W., Gough, P. J., Sehon, C. A., Marquis, R. W., Bertin, J., & Mocarski, E. S. (2013). Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. The Journal of Biological Chemistry, 288(43), 31268\u201331279.","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10096_CR12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ceb.2004.09.011","volume":"16","author":"AL Edinger","year":"2004","unstructured":"Edinger, A. L., & Thompson, C. B. (2004). Death by design: Apoptosis, necrosis and autophagy. Current Opinion in Cell Biology, 16(6), 663\u2013669.","journal-title":"Current Opinion in Cell Biology"},{"issue":"7","key":"10096_CR13","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1161\/ATVBAHA.111.224915","volume":"32","author":"K Konstantinidis","year":"2012","unstructured":"Konstantinidis, K., Whelan, R. S., & Kitsis, R. N. (2012). Mechanisms of cell death in heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 32(7), 1552\u20131562.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"12","key":"10096_CR14","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1089\/ars.2010.3434","volume":"13","author":"MN Jameel","year":"2010","unstructured":"Jameel, M. N., & Zhang, J. (2010). Stem cell therapy for ischemic heart disease. Antioxidants & Redox Signaling, 13(12), 1879\u20131897.","journal-title":"Antioxidants & Redox Signaling"},{"issue":"1","key":"10096_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13287-019-1214-0","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Xu, F., Ma, J., Shi, J., Chen, S., Liu, Z., & Liu, J. (2019). Effect of stem cell transplantation on patients with ischemic heart failure: A systematic review and meta-analysis of randomized controlled trials. Stem Cell Research & Therapy, 10(1), 125.","journal-title":"Stem Cell Research & Therapy"},{"issue":"5","key":"10096_CR16","first-page":"365","volume":"30","author":"TH Chao","year":"2014","unstructured":"Chao, T. H., et al. (2014). Pluripotent stem cell therapy in ischemic cardiovascular disease. Acta Cardiologica Sinica, 30(5), 365\u2013374.","journal-title":"Acta Cardiologica Sinica"},{"issue":"26","key":"10096_CR17","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.2174\/1381612824666180913151059","volume":"24","author":"M Konoplyannikov","year":"2018","unstructured":"Konoplyannikov, M., Kotova, S., Baklaushev, V., Konoplyannikov, A., Kalsin, V., Timashev, P., & Troitskiy, A. (2018). Mesenchymal stem cell therapy for ischemic heart disease: Advances and challenges. Current Pharmaceutical Design, 24(26), 3132\u20133142.","journal-title":"Current Pharmaceutical Design"},{"issue":"3","key":"10096_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2174\/1573403X13666170502103833","volume":"13","author":"R Katarzyna","year":"2017","unstructured":"Katarzyna, R. (2017). Adult stem cell therapy for cardiac repair in patients after acute myocardial infarction leading to ischemic heart failure: An overview of evidence from the recent clinical trials. Current Cardiology Reviews, 13(3), 223\u2013231.","journal-title":"Current Cardiology Reviews"},{"key":"10096_CR19","doi-asserted-by":"crossref","unstructured":"Molkentin, J. D., & Houser, S. R. (2013). Are resident c-kit+ cardiac stem cells really all that are needed to mend a broken heart? Circulation Research, 113(9), 1037\u20131039.","DOI":"10.1161\/CIRCRESAHA.113.302564"},{"issue":"1","key":"10096_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1161\/CIRCRESAHA.115.307934","volume":"118","author":"JH van Berlo","year":"2016","unstructured":"van Berlo, J. H., & Molkentin, J. D. (2016). Most of the dust has settled: cKit+ progenitor cells are an irrelevant source of cardiac myocytes in vivo. Circulation Research, 118(1), 17\u201319.","journal-title":"Circulation Research"},{"issue":"7500","key":"10096_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature13309","volume":"509","author":"JH van Berlo","year":"2014","unstructured":"van Berlo, J. H., Kanisicak, O., Maillet, M., Vagnozzi, R. J., Karch, J., Lin, S. C. J., Middleton, R. C., Marb\u00e1n, E., & Molkentin, J. D. (2014). C-kit+ cells minimally contribute cardiomyocytes to the heart. Nature, 509(7500), 337\u2013341.","journal-title":"Nature"},{"issue":"30","key":"10096_CR22","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1093\/eurheartj\/ehv189","volume":"36","author":"P Menasche","year":"2015","unstructured":"Menasche, P., et al. (2015). Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: First clinical case report. European Heart Journal, 36(30), 2011\u20132017.","journal-title":"European Heart Journal"},{"issue":"1","key":"10096_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.regpep.2003.09.005","volume":"117","author":"YL Tang","year":"2004","unstructured":"Tang, Y. L., Zhao, Q., Zhang, Y. C., Cheng, L., Liu, M., Shi, J., Yang, Y. Z., Pan, C., Ge, J., & Phillips, M. I. (2004). Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regulatory Peptides, 117(1), 3\u201310.","journal-title":"Regulatory Peptides"},{"issue":"4","key":"10096_CR24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nm0405-367","volume":"11","author":"M Gnecchi","year":"2005","unstructured":"Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., & Dzau, V. J. (2005). Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nature Medicine, 11(4), 367\u2013368.","journal-title":"Nature Medicine"},{"key":"10096_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.isci.2018.08.001","volume":"6","author":"X Chen","year":"2018","unstructured":"Chen, X., & Goncalves, M. (2018). DNA, RNA, and protein tools for editing the genetic information in human cells. iScience, 6, 247\u2013263.","journal-title":"iScience"},{"issue":"6","key":"10096_CR26","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1101\/gr.171322.113","volume":"24","author":"S Kim","year":"2014","unstructured":"Kim, S., Kim, D., Cho, S. W., Kim, J., & Kim, J. S. (2014). Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Research, 24(6), 1012\u20131019.","journal-title":"Genome Research"},{"issue":"7629","key":"10096_CR27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature20134","volume":"539","author":"DP Dever","year":"2016","unstructured":"Dever, D. P., Bak, R. O., Reinisch, A., Camarena, J., Washington, G., Nicolas, C. E., Pavel-Dinu, M., Saxena, N., Wilkens, A. B., Mantri, S., Uchida, N., Hendel, A., Narla, A., Majeti, R., Weinberg, K. I., & Porteus, M. H. (2016). CRISPR\/Cas9 beta-globin gene targeting in human haematopoietic stem cells. Nature, 539(7629), 384\u2013389.","journal-title":"Nature"},{"issue":"4","key":"10096_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/bjc.1972.33","volume":"26","author":"JF Kerr","year":"1972","unstructured":"Kerr, J. F., Wyllie, A. H., & Currie, A. R. (1972). Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer, 26(4), 239\u2013257.","journal-title":"British Journal of Cancer"},{"issue":"1","key":"10096_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1469-185X.1951.tb00774.x","volume":"26","author":"A Glucksmann","year":"1951","unstructured":"Glucksmann, A. (1951). Cell deaths in normal vertebrate ontogeny. Biological Reviews of the Cambridge Philosophical Society, 26(1), 59\u201386.","journal-title":"Biological Reviews of the Cambridge Philosophical Society"},{"issue":"6","key":"10096_CR30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/82732","volume":"1","author":"N Holler","year":"2000","unstructured":"Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J. L., Schneider, P., Seed, B., & Tschopp, J. (2000). Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nature Immunology, 1(6), 489\u2013495.","journal-title":"Nature Immunology"},{"issue":"2","key":"10096_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","volume":"114","author":"O Micheau","year":"2003","unstructured":"Micheau, O., & Tschopp, J. (2003). Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell, 114(2), 181\u2013190.","journal-title":"Cell"},{"issue":"7","key":"10096_CR32","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/35080097","volume":"2","author":"RA Lockshin","year":"2001","unstructured":"Lockshin, R. A., & Zakeri, Z. (2001). Programmed cell death and apoptosis: Origins of the theory. Nature Reviews Molecular Cell Biology, 2(7), 545\u2013550.","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"2","key":"10096_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","volume":"116","author":"NN Danial","year":"2004","unstructured":"Danial, N. N., & Korsmeyer, S. J. (2004). Cell death: Critical control points. Cell, 116(2), 205\u2013219.","journal-title":"Cell"},{"issue":"11","key":"10096_CR34","first-page":"2000","volume":"14","author":"BF Trump","year":"1965","unstructured":"Trump, B. F., Goldblatt, P. J., & Stowell, R. E. (1965). Studies of necrosis in vitro of mouse hepatic parenchymal cells. Ultrastructural alterations in endoplasmic reticulum, Golgi apparatus, plasma membrane, and lipid droplets. Laboratory Investigation, 14(11), 2000\u20132028.","journal-title":"Laboratory Investigation"},{"key":"10096_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.semcdb.2018.01.002","volume":"82","author":"MLG Ramirez","year":"2018","unstructured":"Ramirez, M. L. G., & Salvesen, G. S. (2018). A primer on caspase mechanisms. Seminars in Cell & Developmental Biology, 82, 79\u201385.","journal-title":"Seminars in Cell & Developmental Biology"},{"issue":"48","key":"10096_CR36","doi-asserted-by":"publisher","first-page":"6194","DOI":"10.1038\/onc.2008.297","volume":"27","author":"J Li","year":"2008","unstructured":"Li, J., & Yuan, J. (2008). Caspases in apoptosis and beyond. Oncogene, 27(48), 6194\u20136206.","journal-title":"Oncogene"},{"issue":"9","key":"10096_CR37","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/sj.cdd.4401950","volume":"13","author":"C Garrido","year":"2006","unstructured":"Garrido, C., Galluzzi, L., Brunet, M., Puig, P. E., Didelot, C., & Kroemer, G. (2006). Mechanisms of cytochrome c release from mitochondria. Cell Death and Differentiation, 13(9), 1423\u20131433.","journal-title":"Cell Death and Differentiation"},{"issue":"6","key":"10096_CR38","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1096\/fj.08-111005","volume":"23","author":"ME Guicciardi","year":"2009","unstructured":"Guicciardi, M. E., & Gores, G. J. (2009). Life and death by death receptors. The FASEB Journal, 23(6), 1625\u20131637.","journal-title":"The FASEB Journal"},{"issue":"5","key":"10096_CR39","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s10495-007-0723-y","volume":"12","author":"A Rasola","year":"2007","unstructured":"Rasola, A., & Bernardi, P. (2007). The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis, 12(5), 815\u2013833.","journal-title":"Apoptosis"},{"key":"10096_CR40","doi-asserted-by":"publisher","first-page":"128076","DOI":"10.1155\/2015\/128076","volume":"2015","author":"J Belizario","year":"2015","unstructured":"Belizario, J., Vieira-Cordeiro, L., & Enns, S. (2015). Necroptotic cell death signaling and execution pathway: Lessons from knockout mice. Mediators of Inflammation, 2015, 128076.","journal-title":"Mediators of Inflammation"},{"issue":"10","key":"10096_CR41","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/cdd.2014.76","volume":"21","author":"S Orozco","year":"2014","unstructured":"Orozco, S., Yatim, N., Werner, M. R., Tran, H., Gunja, S. Y., Tait, S. W. G., Albert, M. L., Green, D. R., & Oberst, A. (2014). RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death and Differentiation, 21(10), 1511\u20131521.","journal-title":"Cell Death and Differentiation"},{"issue":"3","key":"10096_CR42","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2013.06.018","volume":"39","author":"JM Murphy","year":"2013","unstructured":"Murphy, J. M., Czabotar, P. E., Hildebrand, J. M., Lucet, I. S., Zhang, J. G., Alvarez-Diaz, S., Lewis, R., Lalaoui, N., Metcalf, D., Webb, A. I., Young, S. N., Varghese, L. N., Tannahill, G. M., Hatchell, E. C., Majewski, I. J., Okamoto, T., Dobson, R. C. J., Hilton, D. J., Babon, J. J., Nicola, N. A., Strasser, A., Silke, J., & Alexander, W. S. (2013). The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity, 39(3), 443\u2013453.","journal-title":"Immunity"},{"key":"10096_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev.physiol.010908.163111","volume":"72","author":"RS Whelan","year":"2010","unstructured":"Whelan, R. S., Kaplinskiy, V., & Kitsis, R. N. (2010). Cell death in the pathogenesis of heart disease: Mechanisms and significance. Annual Review of Physiology, 72, 19\u201344.","journal-title":"Annual Review of Physiology"},{"key":"10096_CR44","doi-asserted-by":"publisher","first-page":"7018393","DOI":"10.1155\/2017\/7018393","volume":"2017","author":"M Neri","year":"2017","unstructured":"Neri, M., et al. (2017). Ischemia\/reperfusion injury following acute myocardial infarction: A critical issue for clinicians and forensic pathologists. Mediators of Inflammation, 2017, 7018393.","journal-title":"Mediators of Inflammation"},{"issue":"3","key":"10096_CR45","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"DB Zorov","year":"2014","unstructured":"Zorov, D. B., Juhaszova, M., & Sollott, S. J. (2014). Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiological Reviews, 94(3), 909\u2013950.","journal-title":"Physiological Reviews"},{"issue":"5","key":"10096_CR46","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.bbadis.2016.11.010","volume":"1863","author":"JS Bhatti","year":"2017","unstructured":"Bhatti, J. S., Bhatti, G. K., & Reddy, P. H. (2017). Mitochondrial dysfunction and oxidative stress in metabolic disorders \u2013 a step towards mitochondria based therapeutic strategies. Biochimica et Biophysica Acta \u2013 Molecular Basis of Disease, 1863(5), 1066\u20131077.","journal-title":"Biochimica et Biophysica Acta \u2013 Molecular Basis of Disease"},{"issue":"4","key":"10096_CR47","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.bbamcr.2010.09.013","volume":"1813","author":"KW Kinnally","year":"2011","unstructured":"Kinnally, K. W., Peixoto, P. M., Ryu, S. Y., & Dejean, L. M. (2011). Is mPTP the gatekeeper for necrosis, apoptosis, or both? Biochimica et Biophysica Acta, 1813(4), 616\u2013622.","journal-title":"Biochimica et Biophysica Acta"},{"issue":"7","key":"10096_CR48","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1111\/jcmm.15127","volume":"24","author":"SM Davidson","year":"2020","unstructured":"Davidson, S. M., Adameov\u00e1, A., Barile, L., Cabrera-Fuentes, H. A., Lazou, A., Pagliaro, P., Stensl\u00f8kken, K. O., Garcia-Dorado, D., & the EU\u2010CARDIOPROTECTION COST Action (CA16225). (2020). Mitochondrial and mitochondrial-independent pathways of myocardial cell death during ischaemia and reperfusion injury. Journal of Cellular and Molecular Medicine, 24(7), 3795\u20133806.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"4","key":"10096_CR49","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1159\/000489241","volume":"46","author":"MY Wu","year":"2018","unstructured":"Wu, M. Y., Yiang, G. T., Liao, W. T., Tsai, A. P. Y., Cheng, Y. L., Cheng, P. W., Li, C. Y., & Li, C. J. (2018). Current mechanistic concepts in ischemia and reperfusion injury. Cellular Physiology and Biochemistry, 46(4), 1650\u20131667.","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10096_CR50","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.redox.2014.05.006","volume":"2","author":"T Kalogeris","year":"2014","unstructured":"Kalogeris, T., Bao, Y., & Korthuis, R. J. (2014). Mitochondrial reactive oxygen species: A double edged sword in ischemia\/reperfusion vs preconditioning. Redox Biology, 2, 702\u2013714.","journal-title":"Redox Biology"},{"issue":"2","key":"10096_CR51","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/cvr\/cvs116","volume":"94","author":"D Garcia-Dorado","year":"2012","unstructured":"Garcia-Dorado, D., Ruiz-Meana, M., Inserte, J., Rodriguez-Sinovas, A., & Piper, H. M. (2012). Calcium-mediated cell death during myocardial reperfusion. Cardiovascular Research, 94(2), 168\u2013180.","journal-title":"Cardiovascular Research"},{"issue":"11","key":"10096_CR52","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1136\/hrt.2005.086959","volume":"92","author":"C Basso","year":"2006","unstructured":"Basso, C., & Thiene, G. (2006). The pathophysiology of myocardial reperfusion: A pathologist's perspective. Heart, 92(11), 1559\u20131562.","journal-title":"Heart"},{"issue":"9","key":"10096_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073537","volume":"8","author":"Q Fan","year":"2013","unstructured":"Fan, Q., Huang, Z. M., Boucher, M., Shang, X., Zuo, L., Brinks, H., Lau, W. B., Zhang, J., Chuprun, J. K., & Gao, E. (2013). Inhibition of Fas-associated death domain-containing protein (FADD) protects against myocardial ischemia\/reperfusion injury in a heart failure mouse model. PLoS One, 8(9), e73537.","journal-title":"PLoS One"},{"issue":"9","key":"10096_CR54","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/cdd.2016.46","volume":"23","author":"K Newton","year":"2016","unstructured":"Newton, K., Dugger, D. L., Maltzman, A., Greve, J. M., Hedehus, M., Martin-McNulty, B., Carano, R. A. D., Cao, T. C., van Bruggen, N., Bernstein, L., Lee, W. P., Wu, X., DeVoss, J., Zhang, J., Jeet, S., Peng, I., McKenzie, B. S., Roose-Girma, M., Caplazi, P., Diehl, L., Webster, J. D., & Vucic, D. (2016). RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Cell Death and Differentiation, 23(9), 1565\u20131576.","journal-title":"Cell Death and Differentiation"},{"issue":"6","key":"10096_CR55","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00395-016-0582-1","volume":"111","author":"F Cuello","year":"2016","unstructured":"Cuello, F., & Lorenz, K. (2016). Inhibition of cardiac CaMKII to cure heart failure: Step by step towards translation? Basic Research in Cardiology, 111(6), 66.","journal-title":"Basic Research in Cardiology"},{"issue":"1","key":"10096_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/path.2697","volume":"221","author":"D Glick","year":"2010","unstructured":"Glick, D., Barth, S., & Macleod, K. F. (2010). Autophagy: Cellular and molecular mechanisms. The Journal of Pathology, 221(1), 3\u201312.","journal-title":"The Journal of Pathology"},{"key":"10096_CR57","doi-asserted-by":"crossref","unstructured":"Chun, Y., & Kim, J. (2018). Autophagy: An essential degradation program for cellular homeostasis and life. Cells, 7(12).","DOI":"10.3390\/cells7120278"},{"issue":"10","key":"10096_CR58","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1253\/circj.CJ-13-0835","volume":"77","author":"RL Thomas","year":"2013","unstructured":"Thomas, R. L., & Gustafsson, A. B. (2013). Mitochondrial autophagy \u2013 An essential quality control mechanism for myocardial homeostasis. Circulation Journal, 77(10), 2449\u20132454.","journal-title":"Circulation Journal"},{"key":"10096_CR59","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3389\/fphys.2016.00479","volume":"7","author":"JC Campos","year":"2016","unstructured":"Campos, J. C., et al. (2016). Mitochondrial quality control in cardiac diseases. Frontiers in Physiology, 7, 479.","journal-title":"Frontiers in Physiology"},{"issue":"2","key":"10096_CR60","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/febs.13127","volume":"282","author":"A Kazlauskaite","year":"2015","unstructured":"Kazlauskaite, A., & Muqit, M. M. (2015). PINK1 and Parkin \u2013 Mitochondrial interplay between phosphorylation and ubiquitylation in Parkinson's disease. The FEBS Journal, 282(2), 215\u2013223.","journal-title":"The FEBS Journal"},{"issue":"7","key":"10096_CR61","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1161\/CIRCULATIONAHA.117.029343","volume":"136","author":"T Eschenhagen","year":"2017","unstructured":"Eschenhagen, T., Bolli, R., Braun, T., Field, L. J., Fleischmann, B. K., Fris\u00e9n, J., Giacca, M., Hare, J. M., Houser, S., Lee, R. T., Marb\u00e1n, E., Martin, J. F., Molkentin, J. D., Murry, C. E., Riley, P. R., Ruiz-Lozano, P., Sadek, H. A., Sussman, M. A., & Hill, J. A. (2017). Cardiomyocyte regeneration: A consensus statement. Circulation, 136(7), 680\u2013686.","journal-title":"Circulation"},{"key":"10096_CR62","doi-asserted-by":"publisher","first-page":"9451492","DOI":"10.1155\/2016\/9451492","volume":"2016","author":"A Romito","year":"2016","unstructured":"Romito, A., & Cobellis, G. (2016). Pluripotent stem cells: Current understanding and future directions. Stem Cells International, 2016, 9451492.","journal-title":"Stem Cells International"},{"issue":"4","key":"10096_CR63","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/humrep\/deg143","volume":"18","author":"G de Wert","year":"2003","unstructured":"de Wert, G., & Mummery, C. (2003). Human embryonic stem cells: Research, ethics and policy. Human Reproduction, 18(4), 672\u2013682.","journal-title":"Human Reproduction"},{"issue":"25","key":"10096_CR64","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1093\/eurheartj\/ehz787","volume":"41","author":"M Wysoczynski","year":"2020","unstructured":"Wysoczynski, M., & Bolli, R. (2020). A realistic appraisal of the use of embryonic stem cell-based therapies for cardiac repair. European Heart Journal, 41(25), 2397\u20132404.","journal-title":"European Heart Journal"},{"issue":"7","key":"10096_CR65","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nbt.4162","volume":"36","author":"YW Liu","year":"2018","unstructured":"Liu, Y. W., Chen, B., Yang, X., Fugate, J. A., Kalucki, F. A., Futakuchi-Tsuchida, A., Couture, L., Vogel, K. W., Astley, C. A., Baldessari, A., Ogle, J., Don, C. W., Steinberg, Z. L., Seslar, S. P., Tuck, S. A., Tsuchida, H., Naumova, A. V., Dupras, S. K., Lyu, M. S., Lee, J., Hailey, D. W., Reinecke, H., Pabon, L., Fryer, B. H., MacLellan, W. R., Thies, R. S., & Murry, C. E. (2018). Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates. Nature Biotechnology, 36(7), 597\u2013605.","journal-title":"Nature Biotechnology"},{"issue":"8","key":"10096_CR66","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCRESAHA.119.314869","volume":"124","author":"R Bolli","year":"2019","unstructured":"Bolli, R., & Wysoczynski, M. (2019). Human embryonic stem cell-derived Cardiomyocytes. Circulation Research, 124(8), 1157\u20131159.","journal-title":"Circulation Research"},{"issue":"4","key":"10096_CR67","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663\u2013676.","journal-title":"Cell"},{"issue":"3","key":"10096_CR68","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.227512","volume":"111","author":"CL Mummery","year":"2012","unstructured":"Mummery, C. L., Zhang, J., Ng, E. S., Elliott, D. A., Elefanty, A. G., & Kamp, T. J. (2012). Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: A methods overview. Circulation Research, 111(3), 344\u2013358.","journal-title":"Circulation Research"},{"issue":"6","key":"10096_CR69","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1089\/scd.2011.0075","volume":"21","author":"L Carpenter","year":"2012","unstructured":"Carpenter, L., Carr, C., Yang, C. T., Stuckey, D. J., Clarke, K., & Watt, S. M. (2012). Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. Stem Cells and Development, 21(6), 977\u2013986.","journal-title":"Stem Cells and Development"},{"issue":"6","key":"10096_CR70","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.stem.2014.11.009","volume":"15","author":"L Ye","year":"2014","unstructured":"Ye, L., Chang, Y. H., Xiong, Q., Zhang, P., Zhang, L., Somasundaram, P., Lepley, M., Swingen, C., Su, L., Wendel, J. S., Guo, J., Jang, A., Rosenbush, D., Greder, L., Dutton, J. R., Zhang, J., Kamp, T. J., Kaufman, D. S., Ge, Y., & Zhang, J. (2014). Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell, 15(6), 750\u2013761.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10096_CR71","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s13287-019-1455-y","volume":"10","author":"S Moradi","year":"2019","unstructured":"Moradi, S., Mahdizadeh, H., \u0160ari\u0107, T., Kim, J., Harati, J., Shahsavarani, H., Greber, B., & Moore, J. B., IV. (2019). Research and therapy with induced pluripotent stem cells (iPSCs): Social, legal, and ethical considerations. Stem Cell Research & Therapy, 10(1), 341.","journal-title":"Stem Cell Research & Therapy"},{"issue":"5","key":"10096_CR72","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/stem.37","volume":"27","author":"PS Knoepfler","year":"2009","unstructured":"Knoepfler, P. S. (2009). Deconstructing stem cell tumorigenicity: A roadmap to safe regenerative medicine. Stem Cells, 27(5), 1050\u20131056.","journal-title":"Stem Cells"},{"issue":"2","key":"10096_CR73","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12265-009-9095-8","volume":"2","author":"E Fuh","year":"2009","unstructured":"Fuh, E., & Brinton, T. J. (2009). Bone marrow stem cells for the treatment of ischemic heart disease: A clinical trial review. Journal of Cardiovascular Translational Research, 2(2), 202\u2013218.","journal-title":"Journal of Cardiovascular Translational Research"},{"key":"10096_CR74","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-1-61737-960-4_9","volume":"702","author":"S Gronthos","year":"2011","unstructured":"Gronthos, S., & Zannettino, A. C. (2011). Methods for the purification and characterization of human adipose-derived stem cells. Methods in Molecular Biology, 702, 109\u2013120.","journal-title":"Methods in Molecular Biology"},{"issue":"4","key":"10096_CR75","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1634\/stemcells.22-4-625","volume":"22","author":"K Bieback","year":"2004","unstructured":"Bieback, K., Kern, S., Kl\u00fcter, H., & Eichler, H. (2004). Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells, 22(4), 625\u2013634.","journal-title":"Stem Cells"},{"issue":"12","key":"10096_CR76","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/sctm.17-0129","volume":"6","author":"RM Samsonraj","year":"2017","unstructured":"Samsonraj, R. M., Raghunath, M., Nurcombe, V., Hui, J. H., van Wijnen, A. J., & Cool, S. M. (2017). Concise review: Multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine. Stem Cells Translational Medicine, 6(12), 2173\u20132185.","journal-title":"Stem Cells Translational Medicine"},{"issue":"6","key":"10096_CR77","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/stem.1681","volume":"32","author":"FJ Lv","year":"2014","unstructured":"Lv, F. J., Tuan, R. S., Cheung, K. M. C., & Leung, V. Y. L. (2014). Concise review: The surface markers and identity of human mesenchymal stem cells. Stem Cells, 32(6), 1408\u20131419.","journal-title":"Stem Cells"},{"issue":"3","key":"10096_CR78","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1385\/MB:20:3:245","volume":"20","author":"EJ Caterson","year":"2002","unstructured":"Caterson, E. J., Nesti, L. J., Danielson, K. G., & Tuan, R. S. (2002). Human marrow-derived mesenchymal progenitor cells: Isolation, culture expansion, and analysis of differentiation. Molecular Biotechnology, 20(3), 245\u2013256.","journal-title":"Molecular Biotechnology"},{"key":"10096_CR79","doi-asserted-by":"publisher","first-page":"9628536","DOI":"10.1155\/2019\/9628536","volume":"2019","author":"B Lukomska","year":"2019","unstructured":"Lukomska, B., et al. (2019). Challenges and controversies in human mesenchymal stem cell therapy. Stem Cells International, 2019, 9628536.","journal-title":"Stem Cells International"},{"issue":"23","key":"10096_CR80","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1056\/NEJM200106073442303","volume":"344","author":"AP Beltrami","year":"2001","unstructured":"Beltrami, A. P., Urbanek, K., Kajstura, J., Yan, S. M., Finato, N., Bussani, R., Nadal-Ginard, B., Silvestri, F., Leri, A., Beltrami, C. A., & Anversa, P. (2001). Evidence that human cardiac myocytes divide after myocardial infarction. The New England Journal of Medicine, 344(23), 1750\u20131757.","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"10096_CR81","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0092-8674(03)00687-1","volume":"114","author":"AP Beltrami","year":"2003","unstructured":"Beltrami, A. P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., Kasahara, H., Rota, M., Musso, E., Urbanek, K., Leri, A., Kajstura, J., Nadal-Ginard, B., & Anversa, P. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114(6), 763\u2013776.","journal-title":"Cell"},{"issue":"3","key":"10096_CR82","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.bbrc.2006.11.096","volume":"352","author":"K Tateishi","year":"2007","unstructured":"Tateishi, K., Ashihara, E., Honsho, S., Takehara, N., Nomura, T., Takahashi, T., Ueyama, T., Yamagishi, M., Yaku, H., Matsubara, H., & Oh, H. (2007). Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt\/GSK-3beta signaling. Biochemical and Biophysical Research Communications, 352(3), 635\u2013641.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"10096_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2004.12.097","volume":"107","author":"PM Zavos","year":"2006","unstructured":"Zavos, P. M. (2006). Stem cells and cellular therapy: Potential treatment for cardiovascular diseases. International Journal of Cardiology, 107(1), 1\u20136.","journal-title":"International Journal of Cardiology"},{"issue":"3","key":"10096_CR84","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/1535370213477982","volume":"238","author":"YL Tang","year":"2013","unstructured":"Tang, Y. L., Wang, Y. J., Chen, L. J., Pan, Y. H., Zhang, L., & Weintraub, N. L. (2013). Cardiac-derived stem cell-based therapy for heart failure: Progress and clinical applications. Experimental Biology and Medicine (Maywood, N.J.), 238(3), 294\u2013300.","journal-title":"Experimental Biology and Medicine (Maywood, N.J.)"},{"issue":"39","key":"10096_CR85","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/eurheartj\/ehx454","volume":"38","author":"L Grigorian-Shamagian","year":"2017","unstructured":"Grigorian-Shamagian, L., Liu, W., Fereydooni, S., Middleton, R. C., Valle, J., Cho, J. H., & Marb\u00e1n, E. (2017). Cardiac and systemic rejuvenation after cardiosphere-derived cell therapy in senescent rats. European Heart Journal, 38(39), 2957\u20132967.","journal-title":"European Heart Journal"},{"issue":"1\u20132","key":"10096_CR86","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jacbts.2016.01.003","volume":"1","author":"R Gallet","year":"2016","unstructured":"Gallet, R., de Couto, G., Simsolo, E., Valle, J., Sun, B., Liu, W., Tseliou, E., Zile, M. R., & Marb\u00e1n, E. (2016). Cardiosphere-derived cells reverse heart failure with preserved ejection fraction (HFpEF) in rats by decreasing fibrosis and inflammation. JACC Basic Transl Sci, 1(1\u20132), 14\u201328.","journal-title":"JACC Basic Transl Sci"},{"issue":"12","key":"10096_CR87","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.108.816058","volume":"120","author":"PV Johnston","year":"2009","unstructured":"Johnston, P. V., et al. (2009). Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation, 120(12), 1075\u20131083 7 p following 1083.","journal-title":"Circulation"},{"issue":"4","key":"10096_CR88","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jacc.2010.07.049","volume":"57","author":"ST Lee","year":"2011","unstructured":"Lee, S. T., White, A. J., Matsushita, S., Malliaras, K., Steenbergen, C., Zhang, Y., Li, T. S., Terrovitis, J., Yee, K., Simsir, S., Makkar, R., & Marb\u00e1n, E. (2011). Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. Journal of the American College of Cardiology, 57(4), 455\u2013465.","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10096_CR89","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00395-019-0718-1","volume":"114","author":"DJ Polhemus","year":"2019","unstructured":"Polhemus, D. J., Trivedi, R. K., Sharp, T. E., Li, Z., Goodchild, T. T., Scarborough, A., de Couto, G., Marb\u00e1n, E., & Lefer, D. J. (2019). Repeated cell transplantation and adjunct renal denervation in ischemic heart failure: Exploring modalities for improving cell therapy efficacy. Basic Research in Cardiology, 114(2), 9.","journal-title":"Basic Research in Cardiology"},{"key":"10096_CR90","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fcell.2016.00078","volume":"4","author":"M Wysoczynski","year":"2016","unstructured":"Wysoczynski, M., et al. (2016). A new method to stabilize C-kit expression in reparative cardiac Mesenchymal cells. Frontiers in Cell and Development Biology, 4, 78.","journal-title":"Frontiers in Cell and Development Biology"},{"issue":"9","key":"10096_CR91","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00392-014-0705-3","volume":"103","author":"S Matuszczak","year":"2014","unstructured":"Matuszczak, S., Czapla, J., Jarosz-Biej, M., Wi\u015bniewska, E., Cicho\u0144, T., Smolarczyk, R., Kobusi\u0144ska, M., Gajda, K., Wilczek, P., \u015aliwka, J., Zembala, M., Zembala, M., & Szala, S. (2014). Characteristic of c-kit+ progenitor cells in explanted human hearts. Clinical Research in Cardiology, 103(9), 711\u2013718.","journal-title":"Clinical Research in Cardiology"},{"issue":"5","key":"10096_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096725","volume":"9","author":"KU Hong","year":"2014","unstructured":"Hong, K. U., Guo, Y., Li, Q. H., Cao, P., al-Maqtari, T., Vajravelu, B. N., du, J., Book, M. J., Zhu, X., Nong, Y., Bhatnagar, A., & Bolli, R. (2014). C-kit+ cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart. PLoS One, 9(5), e96725.","journal-title":"PLoS One"},{"issue":"14","key":"10096_CR93","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.jacc.2017.01.048","volume":"69","author":"M Wysoczynski","year":"2017","unstructured":"Wysoczynski, M., Guo, Y., Moore, J. B., IV, Muthusamy, S., Li, Q., Nasr, M., Li, H., Nong, Y., Wu, W., Tomlin, A. A., Zhu, X., Hunt, G., Gumpert, A. M., Book, M. J., Khan, A., Tang, X. L., & Bolli, R. (2017). Myocardial reparative properties of cardiac mesenchymal cells isolated on the basis of adherence. Journal of the American College of Cardiology, 69(14), 1824\u20131838.","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"10096_CR94","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.7150\/thno.41000","volume":"10","author":"JS Heidel","year":"2020","unstructured":"Heidel, J. S., Fischer, A. G., Tang, X. L., Sadri, G., Wu, W. J., Moisa, C. R., Stowers, H., Sandella, N., Wysoczynski, M., Uchida, S., & Moore IV, J. B. (2020). The effect of cardiogenic factors on cardiac Mesenchymal cell anti-Fibrogenic paracrine signaling and therapeutic performance. Theranostics, 10(4), 1514\u20131530.","journal-title":"Theranostics"},{"issue":"948","key":"10096_CR95","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1136\/pgmj.2003.017764","volume":"80","author":"SM Selkirk","year":"2004","unstructured":"Selkirk, S. M. (2004). Gene therapy in clinical medicine. Postgraduate Medical Journal, 80(948), 560\u2013570.","journal-title":"Postgraduate Medical Journal"},{"issue":"10","key":"10096_CR96","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.addr.2009.04.023","volume":"61","author":"MH Hassan","year":"2009","unstructured":"Hassan, M. H., Othman, E. E., Hornung, D., & al-Hendy, A. (2009). Gene therapy of benign gynecological diseases. Advanced Drug Delivery Reviews, 61(10), 822\u2013835.","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"2","key":"10096_CR97","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.ydbio.2010.08.033","volume":"347","author":"Z Chang","year":"2010","unstructured":"Chang, Z., Zhang, Q., Feng, Q., Xu, J., Teng, T., Luan, Q., Shan, C., Hu, Y., Hemmings, B. A., Gao, X., & Yang, Z. (2010). Deletion of Akt1 causes heart defects and abnormal cardiomyocyte proliferation. Developmental Biology, 347(2), 384\u2013391.","journal-title":"Developmental Biology"},{"issue":"8","key":"10096_CR98","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/CIRCRESAHA.110.237156","volume":"108","author":"KM Fischer","year":"2011","unstructured":"Fischer, K. M., Din, S., Gude, N., Konstandin, M. H., Wu, W., Quijada, P., & Sussman, M. A. (2011). Cardiac progenitor cell commitment is inhibited by nuclear Akt expression. Circulation Research, 108(8), 960\u2013970.","journal-title":"Circulation Research"},{"issue":"6","key":"10096_CR99","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ymthe.2006.05.016","volume":"14","author":"N Noiseux","year":"2006","unstructured":"Noiseux, N., Gnecchi, M., Lopez-Ilasaca, M., Zhang, L., Solomon, S. D., Deb, A., Dzau, V. J., & Pratt, R. E. (2006). Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Molecular Therapy, 14(6), 840\u2013850.","journal-title":"Molecular Therapy"},{"issue":"4","key":"10096_CR100","doi-asserted-by":"publisher","first-page":"H1496","DOI":"10.1152\/ajpheart.00365.2011","volume":"301","author":"C Huang","year":"2011","unstructured":"Huang, C., Gu, H., Zhang, W., Manukyan, M. C., Shou, W., & Wang, M. (2011). SDF-1\/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia\/reperfusion injury. American Journal of Physiology. Heart and Circulatory Physiology, 301(4), H1496\u2013H1505.","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"3","key":"10096_CR101","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.pharmthera.2014.03.009","volume":"143","author":"DI Bromage","year":"2014","unstructured":"Bromage, D. I., Davidson, S. M., & Yellon, D. M. (2014). Stromal derived factor 1alpha: A chemokine that delivers a two-pronged defence of the myocardium. Pharmacology & Therapeutics, 143(3), 305\u2013315.","journal-title":"Pharmacology & Therapeutics"},{"issue":"4","key":"10096_CR102","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.ejcts.2009.04.052","volume":"36","author":"J Tang","year":"2009","unstructured":"Tang, J., Wang, J., Yang, J., Kong, X., Zheng, F., Guo, L., Zhang, L., & Huang, Y. (2009). Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. European Journal of Cardio-Thoracic Surgery, 36(4), 644\u2013650.","journal-title":"European Journal of Cardio-Thoracic Surgery"},{"issue":"2","key":"10096_CR103","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.yjmcc.2007.11.010","volume":"44","author":"D Zhang","year":"2008","unstructured":"Zhang, D., Fan, G. C., Zhou, X., Zhao, T., Pasha, Z., Xu, M., Zhu, Y., Ashraf, M., & Wang, Y. (2008). Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. Journal of Molecular and Cellular Cardiology, 44(2), 281\u2013292.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"4","key":"10096_CR104","first-page":"213","volume":"1","author":"MA Rafi","year":"2011","unstructured":"Rafi, M. A. (2011). Gene and stem cell therapy: Alone or in combination? Bioimpacts, 1(4), 213\u2013218.","journal-title":"Bioimpacts"},{"key":"10096_CR105","doi-asserted-by":"publisher","first-page":"1909346","DOI":"10.1155\/2018\/1909346","volume":"2018","author":"H Lemcke","year":"2018","unstructured":"Lemcke, H., et al. (2018). Recent Progress in stem cell modification for cardiac regeneration. Stem Cells International, 2018, 1909346.","journal-title":"Stem Cells International"},{"key":"10096_CR106","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/2277-9175.98152","volume":"1","author":"N Nayerossadat","year":"2012","unstructured":"Nayerossadat, N., Maedeh, T., & Ali, P. A. (2012). Viral and nonviral delivery systems for gene delivery. Advanced Biomedical Research, 1, 27.","journal-title":"Advanced Biomedical Research"},{"issue":"6","key":"10096_CR107","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2174\/15665232113136660005","volume":"13","author":"A Baldo","year":"2013","unstructured":"Baldo, A., van den Akker, E., Bergmans, H. E., Lim, F., & Pauwels, K. (2013). General considerations on the biosafety of virus-derived vectors used in gene therapy and vaccination. Current Gene Therapy, 13(6), 385\u2013394.","journal-title":"Current Gene Therapy"},{"key":"10096_CR108","doi-asserted-by":"crossref","unstructured":"Gaj, T., et al. (2016). Genome-editing technologies: Principles and applications. Cold Spring Harbor Perspectives in Biology, 8(12).","DOI":"10.1101\/cshperspect.a023754"},{"key":"10096_CR109","doi-asserted-by":"crossref","unstructured":"Ricciardi, A. S., et al. (2018). Peptide nucleic acids as a tool for site-specific gene editing. Molecules, 23(3).","DOI":"10.3390\/molecules23030632"},{"issue":"7","key":"10096_CR110","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","volume":"31","author":"T Gaj","year":"2013","unstructured":"Gaj, T., Gersbach, C. A., & Barbas, C. F., 3rd. (2013). ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering. Trends in Biotechnology, 31(7), 397\u2013405.","journal-title":"Trends in Biotechnology"},{"issue":"8","key":"10096_CR111","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nmeth.2030","volume":"9","author":"T Gaj","year":"2012","unstructured":"Gaj, T., Guo, J., Kato, Y., Sirk, S. J., & Barbas, C. F., III. (2012). Targeted gene knockout by direct delivery of zinc-finger nuclease proteins. Nature Methods, 9(8), 805\u2013807.","journal-title":"Nature Methods"},{"key":"10096_CR112","doi-asserted-by":"crossref","unstructured":"Chandrasegaran, S., & Carroll, D. (2016). Origins of programmable nucleases for genome engineering. Journal of Molecular Biology, (428, 5 Pt B), 963\u2013989.","DOI":"10.1016\/j.jmb.2015.10.014"},{"issue":"10","key":"10096_CR113","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1172\/JCI72992","volume":"124","author":"RM Gupta","year":"2014","unstructured":"Gupta, R. M., & Musunuru, K. (2014). Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9. The Journal of Clinical Investigation, 124(10), 4154\u20134161.","journal-title":"The Journal of Clinical Investigation"},{"issue":"12","key":"10096_CR114","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr218","volume":"39","author":"T Cermak","year":"2011","unstructured":"Cermak, T., Doyle, E. L., Christian, M., Wang, L., Zhang, Y., Schmidt, C., Baller, J. A., Somia, N. V., Bogdanove, A. J., & Voytas, D. F. (2011). Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Research, 39(12), e82.","journal-title":"Nucleic Acids Research"},{"issue":"12","key":"10096_CR115","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1128\/jb.169.12.5429-5433.1987","volume":"169","author":"Y Ishino","year":"1987","unstructured":"Ishino, Y., Shinagawa, H., Makino, K., Amemura, M., & Nakata, A. (1987). Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. Journal of Bacteriology, 169(12), 5429\u20135433.","journal-title":"Journal of Bacteriology"},{"issue":"6121","key":"10096_CR116","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., & Zhang, F. (2013). Multiplex genome engineering using CRISPR\/Cas systems. Science, 339(6121), 819\u2013823.","journal-title":"Science"},{"issue":"5","key":"10096_CR117","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/cbic.201800629","volume":"20","author":"L Wang","year":"2019","unstructured":"Wang, L., Zheng, W., Liu, S., Li, B., & Jiang, X. (2019). Delivery of CRISPR\/Cas9 by novel strategies for gene therapy. Chembiochem, 20(5), 634\u2013643.","journal-title":"Chembiochem"},{"key":"10096_CR118","doi-asserted-by":"publisher","first-page":"107501","DOI":"10.1016\/j.pharmthera.2020.107501","volume":"209","author":"J Lee","year":"2020","unstructured":"Lee, J., Bayarsaikhan, D., Bayarsaikhan, G., Kim, J. S., Schwarzbach, E., & Lee, B. (2020). Recent advances in genome editing of stem cells for drug discovery and therapeutic application. Pharmacology & Therapeutics, 209, 107501.","journal-title":"Pharmacology & Therapeutics"},{"key":"10096_CR119","doi-asserted-by":"crossref","unstructured":"Cerbini, T., et al. (2015). Transfection, selection, and colony-picking of human induced pluripotent stem cells TALEN-targeted with a GFP gene into the AAVS1 safe harbor. Journal of Visualized Experiments, 96.","DOI":"10.3791\/52504"},{"issue":"11","key":"10096_CR120","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/s41401-020-0452-0","volume":"41","author":"BC Geng","year":"2020","unstructured":"Geng, B. C., Choi, K. H., Wang, S. Z., Chen, P., Pan, X. D., Dong, N. G., Ko, J. K., & Zhu, H. (2020). A simple, quick, and efficient CRISPR\/Cas9 genome editing method for human induced pluripotent stem cells. Acta Pharmacologica Sinica, 41(11), 1427\u20131432.","journal-title":"Acta Pharmacologica Sinica"},{"issue":"5","key":"10096_CR121","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.stem.2016.04.013","volume":"18","author":"D Hockemeyer","year":"2016","unstructured":"Hockemeyer, D., & Jaenisch, R. (2016). Induced pluripotent stem cells meet genome editing. Cell Stem Cell, 18(5), 573\u2013586.","journal-title":"Cell Stem Cell"},{"key":"10096_CR122","doi-asserted-by":"crossref","unstructured":"Shi, Z.D., et al. (2020). Precision installation of a highly efficient suicide gene safety switch in human induced pluripotent stem cells. Stem Cells Translational Medicine.","DOI":"10.1002\/sctm.20-0007"},{"issue":"12","key":"10096_CR123","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1177\/1947601911423031","volume":"2","author":"M Shibuya","year":"2011","unstructured":"Shibuya, M. (2011). Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A crucial target for anti- and pro-angiogenic therapies. Genes & Cancer, 2(12), 1097\u20131105.","journal-title":"Genes & Cancer"},{"issue":"11","key":"10096_CR124","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0828-282X(07)70845-0","volume":"23","author":"F Gao","year":"2007","unstructured":"Gao, F., He, T., Wang, H. B., Yu, S. Q., Yi, D. H., Liu, W. Y., & Cai, Z. J. (2007). A promising strategy for the treatment of ischemic heart disease: Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats. The Canadian Journal of Cardiology, 23(11), 891\u2013898.","journal-title":"The Canadian Journal of Cardiology"},{"issue":"2","key":"10096_CR125","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/bjp.2008.349","volume":"157","author":"D Bouard","year":"2009","unstructured":"Bouard, D., Alazard-Dany, D., & Cosset, F. L. (2009). Viral vectors: From virology to transgene expression. British Journal of Pharmacology, 157(2), 153\u2013165.","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10096_CR126","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/sctm.16-0114","volume":"6","author":"HM Cho","year":"2017","unstructured":"Cho, H. M., Kim, P. H., Chang, H. K., Shen, Y. M., Bonsra, K., Kang, B. J., Yum, S. Y., Kim, J. H., Lee, S. Y., Choi, M. C., Kim, H. H., Jang, G., & Cho, J. Y. (2017). Targeted genome engineering to control VEGF expression in human umbilical cord blood-derived Mesenchymal stem cells: Potential implications for the treatment of myocardial infarction. Stem Cells Translational Medicine, 6(3), 1040\u20131051.","journal-title":"Stem Cells Translational Medicine"},{"issue":"9","key":"10096_CR127","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/mt.2016.120","volume":"24","author":"HK Chang","year":"2016","unstructured":"Chang, H. K., Kim, P. H., Cho, H. M., Yum, S. Y., Choi, Y. J., Son, Y. S., Lee, D. B., Kang, I. S., Kang, K. S., Jang, G., & Cho, J. Y. (2016). Inducible HGF-secreting human umbilical cord blood-derived MSCs produced via TALEN-mediated genome editing promoted angiogenesis. Molecular Therapy, 24(9), 1644\u20131654.","journal-title":"Molecular Therapy"},{"issue":"9","key":"10096_CR128","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s12276-018-0143-9","volume":"50","author":"HK Chang","year":"2018","unstructured":"Chang, H. K., Kim, P. H., Kim, D. W., Cho, H. M., Jeong, M. J., Kim, D. H., Joung, Y. K., Lim, K. S., Kim, H. B., Lim, H. C., Han, D. K., Hong, Y. J., & Cho, J. Y. (2018). Coronary stents with inducible VEGF\/HGF-secreting UCB-MSCs reduced restenosis and increased re-endothelialization in a swine model. Experimental & Molecular Medicine, 50(9), 114.","journal-title":"Experimental & Molecular Medicine"},{"issue":"15","key":"10096_CR129","doi-asserted-by":"publisher","first-page":"6898","DOI":"10.7150\/thno.42347","volume":"10","author":"L Wang","year":"2020","unstructured":"Wang, L., Zhang, F., Duan, F., Huang, R., Chen, X., Ming, J., & Na, J. (2020). Homozygous MESP1 knock-in reporter hESCs facilitated cardiovascular cell differentiation and myocardial infarction repair. Theranostics, 10(15), 6898\u20136914.","journal-title":"Theranostics"},{"key":"10096_CR130","doi-asserted-by":"crossref","unstructured":"Cadigan, K. M., & Waterman, M. L. (2012). TCF\/LEFs and Wnt signaling in the nucleus. Cold Spring Harbor Perspectives in Biology, 4(11).","DOI":"10.1101\/cshperspect.a007906"},{"issue":"6","key":"10096_CR131","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41374-019-0204-2","volume":"99","author":"B Ye","year":"2019","unstructured":"Ye, B., Li, L., Xu, H., Chen, Y., & Li, F. (2019). Opposing roles of TCF7\/LEF1 and TCF7L2 in cyclin D2 and Bmp4 expression and cardiomyocyte cell cycle control during late heart development. Laboratory Investigation, 99(6), 807\u2013818.","journal-title":"Laboratory Investigation"},{"key":"10096_CR132","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.omtn.2020.01.007","volume":"19","author":"HM Cho","year":"2020","unstructured":"Cho, H. M., Lee, K. H., Shen, Y. M., Shin, T. J., Ryu, P. D., Choi, M. C., Kang, K. S., & Cho, J. Y. (2020). Transplantation of hMSCs genome edited with LEF1 improves cardio-protective effects in myocardial infarction. Molecular Therapy-Nucleic Acids, 19, 1186\u20131197.","journal-title":"Molecular Therapy-Nucleic Acids"},{"key":"10096_CR133","doi-asserted-by":"crossref","unstructured":"Ostrominski, J.W., et al. (2020). CRISPR\/Cas9-mediated introduction of the sodium\/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell-derived cardiomyocytes. Stem Cells Translational Medicine.","DOI":"10.1002\/sctm.20-0019"},{"issue":"3","key":"10096_CR134","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/intimm\/dxg042","volume":"15","author":"A Bodnar","year":"2003","unstructured":"Bodnar, A., et al. (2003). Class IHLA oligomerization at the surface of B cells is controlled by exogenous beta(2)-microglobulin: Implications in activation of cytotoxic T lymphocytes. International Immunology, 15(3), 331\u2013339.","journal-title":"International Immunology"},{"issue":"10","key":"10096_CR135","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.5966\/sctm.2015-0049","volume":"4","author":"DC Wang","year":"2015","unstructured":"Wang, D. C., et al. (2015). Targeted disruption of the beta(2)-microglobulin gene minimizes the immunogenicity of human embryonic stem cells. Stem Cells Translational Medicine, 4(10), 1234\u20131245.","journal-title":"Stem Cells Translational Medicine"},{"issue":"5","key":"10096_CR136","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s00018-019-03220-3","volume":"77","author":"LB Shao","year":"2020","unstructured":"Shao, L. B., et al. (2020). Knockout of beta-2 microglobulin enhances cardiac repair by modulating exosome imprinting and inhibiting stem cell-induced immune rejection. Cellular and Molecular Life Sciences, 77(5), 937\u2013952.","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"4","key":"10096_CR137","doi-asserted-by":"publisher","first-page":"728","DOI":"10.33594\/000000051","volume":"52","author":"D Meng","year":"2019","unstructured":"Meng, D., Han, S., Jeong, I. S., & Kim, S. W. (2019). Interleukin 10-secreting MSCs via TALEN-mediated gene editing attenuates left ventricular remodeling after myocardial infarction. Cellular Physiology and Biochemistry, 52(4), 728\u2013741.","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10096_CR138","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13036-019-0163-6","volume":"13","author":"X Meng","year":"2019","unstructured":"Meng, X., Zheng, M., Yu, M., Bai, W., Zuo, L., Bu, X., Liu, Y., Xia, L., Hu, J., Liu, L., & Li, J. (2019). Transplantation of CRISPRa system engineered IL10-overexpressing bone marrow-derived mesenchymal stem cells for the treatment of myocardial infarction in diabetic mice. Journal of Biological Engineering, 13, 49.","journal-title":"Journal of Biological Engineering"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-020-10096-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-020-10096-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-020-10096-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T03:12:19Z","timestamp":1697685139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-020-10096-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":138,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10096"],"URL":"https:\/\/doi.org\/10.1007\/s12015-020-10096-5","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,25]]},"assertion":[{"value":"25 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}